These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3574140

  • 1. Comparison of calcium, calcitriol, ovarian hormones and nandrolone in the treatment of osteoporosis.
    Need AG, Chatterton BE, Walker CJ, Steurer TA, Horowitz M, Nordin BE.
    Maturitas; 1986 Dec; 8(4):275-80. PubMed ID: 3574140
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of nandrolone decanoate on forearm mineral density and calcium metabolism in osteoporotic postmenopausal women.
    Need AG, Morris HA, Hartley TF, Horowitz M, Nordin BE.
    Calcif Tissue Int; 1987 Jul; 41(1):7-10. PubMed ID: 3113703
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S, Rossini M.
    Wien Med Wochenschr; 1993 Jul; 143(14-15):395-7. PubMed ID: 8256456
    [Abstract] [Full Text] [Related]

  • 10. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study.
    Geusens P, Dequeker J.
    Bone Miner; 1986 Sep; 1(4):347-57. PubMed ID: 3333018
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study.
    Ebeling PR, Wark JD, Yeung S, Poon C, Salehi N, Nicholson GC, Kotowicz MA.
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4098-103. PubMed ID: 11549632
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Double-blind placebo-controlled trial of treatment of osteoporosis with the anabolic nandrolone decanoate.
    Need AG, Nordin BE, Chatterton BE.
    Osteoporos Int; 1993 Sep; 3 Suppl 1():218-22. PubMed ID: 8461566
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anabolic steroids and osteoporosis.
    Dequeker J, Geusens P.
    Acta Endocrinol Suppl (Copenh); 1985 Sep; 271():45-52. PubMed ID: 3865481
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.